Supportive therapy for ovarian cancer

Abstract

Surgery is the main treatment for patients suffering from ovarian cancer. But, the therapy successes of this pathology have been primarily associated with the effective drug treatment in recent years. New drugs and chemotherapy regimens have significantly changed the principles of medicinal treatment of the disease and helped to add supportive part of therapy. Supportive therapy was considered inappropriate due to limited efficacy and high toxicity 5 years ago.

Keywords

• ovarian cancer
• supportive therapy for primary ovarian cancer
• supportive therapy for recurrent ovarian cancer
• brca mutation
• brca-associated ovarian cancer
• olaparib